XML 34 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION
12 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
STOCK-BASED COMPENSATON
9.
STOCK-BASED COMPENSATION
 
Summary of Stock Option Plans and Activity
 
In March 2008, our shareholders approved the 2008 Stock Option Plan (the “Plan”) to replace the 1997 Outside Director Stock Option Plan and the 1997 Employee Stock Option Plan. Future common shares will be granted from the 2008 Stock Option Plan. The purpose of the Plan is to promote our long-term interests by providing a means of attracting and retaining officers, directors and key employees. The Compensation Committee administers the Plan and approves the particular officers, directors or employees eligible for grants. Under the Plan, employees are granted the option to purchase our common shares at fair market value on the date of the grant. Generally, options granted vest and become exercisable in four equal installments commencing one year from date of grant and expire upon the earlier of the employee’s termination of employment with us, or ten years from the date of grant. The Plan terminates in fiscal 2018. The maximum number of common shares that may be granted under the Plan is 500 shares. At September 30, 2017, 278 shares remained available for grants under the Plan.
 
The Compensation Committee has also issued non-qualified stock option grants with vesting periods different from the Plan. As of September 30, 2017 and 2016, respectively, total non-qualified stock options outstanding were 15.
 
No options were granted in fiscal 2017. The weighted-average assumptions used to compute the fair value of options granted for the fiscal year ended September 30, 2016 were as follows:
 
  2016 
Risk-free interest rate  1.58%
Dividend yield  0.00%
Volatility of the expected market price of the Company’s common shares  97.50%-97.50%
Expected life of the options (years)  8.0 
 
A summary of our stock option activity for all options and related information for the years ended September 30, 2017 and 2016, respectively, is as follows (in thousands except for share prices):
 
  Options
(shares)
 Weighted-
Average 
Exercise 
Price
 Weighted-
Average
Grant Date 
Fair Value
 Weighted-
Average 
Remaining 
Contractual 
Life
 Aggregate 
Intrinsic 
Value
 
                 
Outstanding - October 1, 2015  319 $1.73          
Exercised  (3) $1.14 $0.95       
Granted  10 $0.94 $0.79       
Terminated  (64) $1.49          
Outstanding - September 30, 2016  262 $1.76 $1.39       
                 
Outstanding - October 1, 2016  262 $1.76          
Exercised  (72) $1.23 $1.02       
Granted   $ $       
Terminated  (50) $2.11          
Outstanding - September 30, 2017  140 $1.91 $1.45  5.6 $45 
                 
Exercisable at September 30, 2017  111 $1.98 $1.47  5.0 $39 
 
The aggregate intrinsic value is the product of the total options outstanding and the net positive difference of our common share price on September 30, 2017 and the options’ exercise price.
 
As of September 30, 2017, our total unrecognized compensation cost related to non-vested stock options was $34 and is expected to be recognized over a weighted-average service period of 1.1 years. As of September 30, 2017, there are 15 shares underlying outstanding options that were granted outside of the Plan. Stock-based compensation expense for employee stock options for the years ended September 30, 2017 and 2016 was $19 and $45, respectively.
 
The following table summarizes outstanding and exercisable options as of September 30, 2017 (in thousands except per share amounts):
 

     Weighted          
     average Weighted    Weighted 
Range of    Remaining average    average 
Exercise 
Prices
 Options
Outstanding
 Contractual
Life (Yrs)
 Exercise
Price
 Options 
Exercisable
 Exercise 
Price
 
$0.79 - $1.50  74  5.28 $1.17  67 $1.19 
$1.51 - $4.00  50  7.60 $1.96  28 $2.03 
$4.01 - $8.79  16  0.93 $5.09  16 $5.09